Bio-Techne (TECH) EBT (2009 - 2026)

Bio-Techne's EBT history runs 18 years deep, the most recent figure standing at $71.2 million for Q1 2026.

• On a quarterly basis, EBT rose 86.09% year-over-year to $71.2 million in Q1 2026; TTM through Mar 2026 was $60.3 million, a 60.34% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, down 93.34% from the prior year.
• EBT rose to $71.2 million in Q1 2026 per TECH's latest filing, from $50.8 million in the prior quarter.
• Across five years, EBT topped out at $103.7 million in Q3 2022 and bottomed at -$109.7 million in Q2 2025.
• The 5-year median for EBT is $50.8 million (2025), against an average of $49.6 million.
• Across the five-year window, EBT surged 1011.37% in 2022 and sank 456.34% in 2025, its largest moves.
• Year by year, EBT stood at $66.4 million in 2022, then tumbled by 49.74% to $33.4 million in 2023, then grew by 28.42% to $42.9 million in 2024, then rose by 18.44% to $50.8 million in 2025, then soared by 40.25% to $71.2 million in 2026.
• Per Business Quant, the three latest TECH EBT figures stand at $71.2 million (Q1 2026), $50.8 million (Q4 2025), and $48.0 million (Q3 2025).